Brave Asset Management’s RadNet RDNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$727K Hold
11,791
0.16% 64
2026
Q1
$659K Hold
11,791
0.15% 71
2025
Q4
$841K Hold
11,791
0.2% 49
2025
Q3
$899K Hold
11,791
0.22% 51
2025
Q2
$671K Hold
11,791
0.18% 66
2025
Q1
$586K Hold
11,791
0.18% 64
2024
Q4
$823K Hold
11,791
0.26% 45
2024
Q3
$818K Hold
11,791
0.2% 53
2024
Q2
$695K Hold
11,791
0.18% 55
2024
Q1
$574K Hold
11,791
0.15% 69
2023
Q4
$410K Hold
11,791
0.12% 82
2023
Q3
$332K Hold
11,791
0.1% 86
2023
Q2
$385K Hold
11,791
0.11% 80
2023
Q1
$295K Hold
11,791
0.09% 91
2022
Q4
$222K Hold
11,791
0.08% 117
2022
Q3
$240K Hold
11,791
0.12% 99
2022
Q2
$204K Hold
11,791
0.09% 123
2022
Q1
$264K Hold
11,791
0.09% 116
2021
Q4
$355K Sell
11,791
-2,200
-16% -$64.8K 0.1% 90
2021
Q3
$410K Hold
13,991
0.12% 82
2021
Q2
$471K Sell
13,991
-1,413
-9% -$37.2K 0.14% 76
2021
Q1
$335K Sell
15,404
-4,126
-21% -$83.5K 0.11% 96
2020
Q4
$382K Buy
+19,530
New +$345K 0.15% 76

Other funds holding RDNT

Brave Asset Management's RDNT Position: Q2 2026 in Review

Brave Asset Management held its RadNet (RDNT) position steady in Q2 2026 at 11,791 shares worth $727K. The position accounts for 0.16% of the portfolio, ranked #64.

Brave Asset Management first reported a position in RDNT in Q4 2020 and has held it in 23 quarters since. The position peaked at $899K in Q3 2025. 328 funds tracked by Wall St. Rank hold RDNT as of Q2 2026.

  • Brave Asset Management held 11,791 shares of RadNet worth $727K as of Q2 2026.
  • Brave Asset Management left its RadNet share count unchanged in Q2 2026.
  • RadNet made up 0.16% of Brave Asset Management's portfolio in Q2 2026, its #64 holding.
  • Brave Asset Management first reported a position in RadNet in Q4 2020 and has held it in 23 quarters since.
  • Brave Asset Management's RadNet position peaked at $899K in Q3 2025.
  • 328 funds tracked by Wall St. Rank held RadNet as of Q2 2026.

Based on Brave Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.